- Home
- KNSA vs BFH Comparison
KNSA vs BFH Comparison
Compare KNSA & BFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KNSA | BFH |
|---|---|---|
| Founded | 2015 | 1996 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.5B |
| IPO Year | 2018 | 2000 |
Fundamental Metrics
Financial Performance| Metric | KNSA | BFH |
|---|---|---|
| Price | $53.51 | $86.39 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 15 |
| Target Price | $60.86 | ★ $80.64 |
| AVG Volume (30 Days) | ★ 689.2K | 528.5K |
| Earning Date | 04-28-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 1.08% |
| EPS Growth | ★ 225.00 | 98.36 |
| EPS | 0.27 | ★ 4.15 |
| Revenue | $677,564,000.00 | ★ $4,521,400,000.00 |
| Revenue This Year | $37.48 | $53.25 |
| Revenue Next Year | $17.87 | $3.53 |
| P/E Ratio | $199.89 | ★ $20.62 |
| Revenue Growth | ★ 60.09 | N/A |
| 52 Week Low | $26.27 | $49.17 |
| 52 Week High | $59.87 | $99.13 |
Technical Indicators
Market Signals| Indicator | KNSA | BFH |
|---|---|---|
| Relative Strength Index (RSI) | 51.48 | 55.06 |
| Support Level | $40.67 | $82.58 |
| Resistance Level | $59.87 | $89.00 |
| Average True Range (ATR) | 2.10 | 2.67 |
| MACD | -0.74 | -0.26 |
| Stochastic Oscillator | 17.59 | 71.67 |
Price Performance
Historical ComparisonAbout KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
About BFH Bread Financial Holdings Inc.
Formed by a combination of JCPenney's credit card processing unit and The Limited's credit card bank business, Bread Financial is a provider of private-label and co-branded credit cards, loyalty programs, and marketing services. The company's most financially significant unit is its credit card business that partners with retailers to jointly market Bread's credit cards to their customers. The company also retains a minority interest in spun-off LoyaltyOne, which operates the largest airline miles loyalty program in Canada and offers marketing services to grocery chains in Europe and Asia.